Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis

NCT02337608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: GLPG1205
DRUG: Placebo

Sponsor

Lakefront Biotherapeutics NV